BPC
AGIO icon

Banque Pictet & Cie’s Agios Pharmaceuticals AGIO Stock Holding History

Banque Pictet & Cie’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,580
Closed -$210K – 466
2014
Q2 		$210K Buy
+4,580
New +$187K 0.01% 423

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Pictet & Cie's AGIO Position: Q3 2014 in Review

Banque Pictet & Cie sold out of Agios Pharmaceuticals (AGIO) in Q3 2014, closing a stake of 4,580 shares — an estimated $210K sold.

Banque Pictet & Cie first reported a position in AGIO in Q2 2014 and held it in 1 quarter. The position peaked at $210K in Q2 2014. 120 funds tracked by Wall St. Rank hold AGIO as of Q3 2014.

  • Banque Pictet & Cie reported no remaining Agios Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 4,580 Agios Pharmaceuticals shares in Q3 2014, an estimated $210K.
  • Banque Pictet & Cie first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Banque Pictet & Cie's Agios Pharmaceuticals position peaked at $210K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2014.

Based on Banque Pictet & Cie's 13F filing for Q3 2014, filed 7 Nov 2014.